Forskningsdatasæt
- 7 resultater
Søgeresultater
-
Additional file 1 of Longitudinal minimal residual disease assessment in multiple myeloma patients in complete remission – results from the NMSG flow-MRD substudy within the EMN02/HO95 MM trial
Schmitz, A. (Ophavsperson), Brøndum, R. F. (Ophavsperson), Johnsen, H. E. (Ophavsperson), Mellqvist, U. (Ophavsperson), Waage, A. (Ophavsperson), Gimsing, P. (Ophavsperson), op Bruinink, D. H. (Ophavsperson), van der Velden, V. (Ophavsperson), van der Holt, B. (Ophavsperson), Hansson, M. (Ophavsperson), Andersen, N. F. (Ophavsperson), Frølund, U. C. (Ophavsperson), Helleberg, C. (Ophavsperson), Schjesvold, F. H. (Ophavsperson), Ahlberg, L. (Ophavsperson), Gulbrandsen, N. (Ophavsperson), Andreasson, B. (Ophavsperson), Lauri, B. (Ophavsperson), Haukas, E. (Ophavsperson), Bødker, J. S. (Ophavsperson), Roug, A. S. (Ophavsperson), Bøgsted, M. (Ophavsperson), Severinsen, M. T. (Ophavsperson), Gregersen, H. E. (Ophavsperson), Abildgaard, N. (Ophavsperson), Sonneveld, P. (Ophavsperson) & Dybkær, K. (Ophavsperson), Figshare, 2022
DOI: 10.6084/m9.figshare.19128644.v1, https://springernature.figshare.com/articles/journal_contribution/Additional_file_1_of_Longitudinal_minimal_residual_disease_assessment_in_multiple_myeloma_patients_in_complete_remission_results_from_the_NMSG_flow-MRD_substudy_within_the_EMN02_HO95_MM_trial/19128644/1
Datasæt
-
Longitudinal minimal residual disease assessment in multiple myeloma patients in complete remission – results from the NMSG flow-MRD substudy within the EMN02/HO95 MM trial
Schmitz, A. (Ophavsperson), Brøndum, R. F. (Ophavsperson), Johnsen, H. E. (Ophavsperson), Mellqvist, U. (Ophavsperson), Waage, A. (Ophavsperson), Gimsing, P. (Ophavsperson), op Bruinink, D. H. (Ophavsperson), van der Velden, V. (Ophavsperson), van der Holt, B. (Ophavsperson), Hansson, M. (Ophavsperson), Andersen, N. F. (Ophavsperson), Frølund, U. C. (Ophavsperson), Helleberg, C. (Ophavsperson), Schjesvold, F. H. (Ophavsperson), Ahlberg, L. (Ophavsperson), Gulbrandsen, N. (Ophavsperson), Andreasson, B. (Ophavsperson), Lauri, B. (Ophavsperson), Haukas, E. (Ophavsperson), Bødker, J. S. (Ophavsperson), Roug, A. S. (Ophavsperson), Bøgsted, M. (Ophavsperson), Severinsen, M. T. (Ophavsperson), Gregersen, H. E. (Ophavsperson), Abildgaard, N. (Ophavsperson), Sonneveld, P. (Ophavsperson) & Dybkær, K. (Ophavsperson), Figshare, 2022
DOI: 10.6084/m9.figshare.c.5827973, https://springernature.figshare.com/collections/Longitudinal_minimal_residual_disease_assessment_in_multiple_myeloma_patients_in_complete_remission_results_from_the_NMSG_flow-MRD_substudy_within_the_EMN02_HO95_MM_trial/5827973
Datasæt
-
Longitudinal minimal residual disease assessment in multiple myeloma patients in complete remission – results from the NMSG flow-MRD substudy within the EMN02/HO95 MM trial
Schmitz, A. (Ophavsperson), Brøndum, R. F. (Ophavsperson), Johnsen, H. E. (Ophavsperson), Mellqvist, U. (Ophavsperson), Waage, A. (Ophavsperson), Gimsing, P. (Ophavsperson), op Bruinink, D. H. (Ophavsperson), van der Velden, V. (Ophavsperson), van der Holt, B. (Ophavsperson), Hansson, M. (Ophavsperson), Andersen, N. F. (Ophavsperson), Frølund, U. C. (Ophavsperson), Helleberg, C. (Ophavsperson), Schjesvold, F. H. (Ophavsperson), Ahlberg, L. (Ophavsperson), Gulbrandsen, N. (Ophavsperson), Andreasson, B. (Ophavsperson), Lauri, B. (Ophavsperson), Haukas, E. (Ophavsperson), Bødker, J. S. (Ophavsperson), Roug, A. S. (Ophavsperson), Bøgsted, M. (Ophavsperson), Severinsen, M. T. (Ophavsperson), Gregersen, H. E. (Ophavsperson), Abildgaard, N. (Ophavsperson), Sonneveld, P. (Ophavsperson) & Dybkær, K. (Ophavsperson), Figshare, 2022
DOI: 10.6084/m9.figshare.c.5827973.v1, https://springernature.figshare.com/collections/Longitudinal_minimal_residual_disease_assessment_in_multiple_myeloma_patients_in_complete_remission_results_from_the_NMSG_flow-MRD_substudy_within_the_EMN02_HO95_MM_trial/5827973/1
Datasæt
-
Supplementary Table_S1: Direct costs of antineoplastic and supportive treatment for progressive multiple myeloma in a tax-based health system.xlsx
Brøndum, R. F. (Ophavsperson), Vestergaard, A. S. (Ophavsperson), Børty, L. (Ophavsperson), Vesteghem, C. P. E. (Ophavsperson), Rytter, A. S. (Ophavsperson), Nielsen, M. M. (Ophavsperson), Severinsen, M. T. (Ophavsperson), Jensen, P. (Ophavsperson), Gregersen, H. E. (Ophavsperson), El-Galaly, T. C. (Ophavsperson), Dybkær, K. (Ophavsperson), Ehlers, L. H. (Ophavsperson), Bøgsted, M. (Ophavsperson) & Roug, A. S. (Ophavsperson), Future Science Group, 22 jun. 2021
DOI: 10.25402/fon.14823033.v1, https://future-science-group.figshare.com/articles/dataset/Supplementary_Table_S1_Direct_costs_of_antineoplastic_and_supportive_treatment_for_progressive_multiple_myeloma_in_a_tax-based_health_system_xlsx/14823033/1
Datasæt: Supplerende materiale
-
Supplementary Table_S1: Direct costs of antineoplastic and supportive treatment for progressive multiple myeloma in a tax-based health system.xlsx
Brøndum, R. F. (Ophavsperson), Vestergaard, A. S. (Ophavsperson), Børty, L. (Ophavsperson), Vesteghem, C. P. E. (Ophavsperson), Rytter, A. S. (Ophavsperson), Nielsen, M. M. (Ophavsperson), Severinsen, M. T. (Ophavsperson), Jensen, P. (Ophavsperson), Gregersen, H. E. (Ophavsperson), El-Galaly, T. C. (Ophavsperson), Dybkær, K. (Ophavsperson), Ehlers, L. H. (Ophavsperson), Bøgsted, M. (Ophavsperson) & Roug, A. S. (Ophavsperson), Future Science Group, 2021
DOI: 10.25402/fon.14823033, https://future-science-group.figshare.com/articles/dataset/Supplementary_Table_S1_Direct_costs_of_antineoplastic_and_supportive_treatment_for_progressive_multiple_myeloma_in_a_tax-based_health_system_xlsx/14823033
Datasæt: Supplerende materiale
-
Supplementary Material for: Antigen Expression Varies Significantly between Molecular Subgroups of Acute Myeloid Leukemia Patients: Clinical Applicability Is Hampered by Establishment of Relevant Cutoffs
Herborg, L. L. (Ophavsperson), Nederby, L. (Ophavsperson), Brøndum, R. F. (Ophavsperson), Hansen, M. (Ophavsperson), Hokland, P. (Ophavsperson) & Roug, A. S. (Ophavsperson), Karger Publishers, 3 dec. 2020
DOI: 10.6084/m9.figshare.13325804.v1, https://doi.org/10.6084%2Fm9.figshare.13325804.v1
Datasæt: Supplerende materiale
-
Supplementary Material for: Antigen Expression Varies Significantly between Molecular Subgroups of Acute Myeloid Leukemia Patients: Clinical Applicability Is Hampered by Establishment of Relevant Cutoffs
Herborg, L. L. (Ophavsperson), Nederby, L. (Ophavsperson), Brøndum, R. F. (Ophavsperson), Hansen, M. (Ophavsperson), Hokland, P. (Ophavsperson) & Roug, A. S. (Ophavsperson), Karger Publishers, 2020
DOI: 10.6084/m9.figshare.13325804, https://karger.figshare.com/articles/dataset/Supplementary_Material_for_Antigen_Expression_Varies_Significantly_between_Molecular_Subgroups_of_Acute_Myeloid_Leukemia_Patients_Clinical_Applicability_Is_Hampered_by_Establishment_of_Relevant_Cutoffs/13325804
Datasæt: Supplerende materiale